Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology

• Informing an investment case for Japanese encephalitis vaccine introduction in Bangladesh. (August 9, 2024)
• Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study. (May 27, 2024)
• Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study. (May 9, 2023)
• Extent of disability among paediatric Japanese encephalitis survivors and predictors of poor outcome: a retrospective cohort study in North India. (October 31, 2022)
• Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis. (June 9, 2022)
• Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization.  (January 2021)
• Distribution of Japanese Encephalitis Virus, Japan and Southeast Asia, 2016–2018. (January 2020)
• Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travelers. (May 1, 2018)
• Control of Japanese encephalitis in Asia: the time is now. (June 13, 2014)

Clinical Information and Management

• A Clear and Present Danger: Encephalitis Due to Infection With Normocellular Cerebrospinal Fluid. (August 3, 2024)
• Japanese Encephalitis Emergence in Australia: The Potential Population at Risk.  (October 3, 2022)
• Proteomic landscape subtype and clinical prognosis of patients with the cognitive impairment by Japanese encephalitis infection. (April 4, 2022)
• Japanese Encephalitis Virus as Cause of Acute Encephalitis, Bhutan. (September 2020)
• A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute Encephalitis. (May 20, 2020)
• Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection. (February 21, 2020)
• Japanese encephalitis — the prospects for new treatments. (May, 2018)

Vaccination

• Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh. (December, 2024)
• A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers. (August 21, 2023)
• Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines.    (March 27, 2023)
• Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial. (February 2022)
• The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control. (June 15, 2021)
• Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis. (July 29, 2015)
• Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009–2012. (January 29, 2015)